Your browser doesn't support javascript.
loading
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome.
Mezquita, Laura; Jové, Maria; Nadal, Ernest; Kfoury, Maria; Morán, Teresa; Ricordel, Charles; Dhooge, Marion; Tlemsani, Camille; Léna, Hervé; Teulé, Alex; Álvarez, Jose-Valero; Raimbourg, Judith; Hiret, Sandrine; Lacroix, Ludovic; Menéndez, Mireia; Saldaña, Juana; Brunet, Joan; Lianes, Pilar; Coupier, Isabelle; Auclin, Edouard; Recondo, Gonzalo; Friboulet, Luc; Adam, Julien; Green, Emma; Planchard, David; Frébourg, Thierry; Capellà, Gabriel; Rouleau, Etienne; Lázaro, Conxi; Caron, Olivier; Besse, Benjamin.
Afiliación
  • Mezquita L; Thoracic Oncology Group, Cancer Medicine Department, Gustave Roussy, Villejuif, France; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain.
  • Jové M; Medical Oncology Department, Catalan Institute of Oncology (ICO-IDIBELL-ONCOBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Nadal E; Medical Oncology Department, Catalan Institute of Oncology (ICO-IDIBELL-ONCOBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Kfoury M; Thoracic Oncology Group, Cancer Medicine Department, Gustave Roussy, Villejuif, France.
  • Morán T; Medical Oncology Department, Catalan Institute of Oncology-Badalona (ICO-Badalona), Institut Germans Trias i Pujol (IGTP), Badalona Applied Research Group in Oncology (B-ARGO), Universitat Autònoma de Barcelona (UAB), Medicine Department, Badalona, Spain.
  • Ricordel C; Department of Respiratory Medicine, Pontchaillou Hospital, Rennes, France; University of Rennes, Rennes, France; Chemistry, Oncogenesis, and Stress Signaling, INSERM, Centre Eugène Marquis, Rennes, France.
  • Dhooge M; Gastroenterology Department, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Tlemsani C; Medical Oncology Department, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Cancer Research for PErsonalized Medicine (CARPEM), Paris, France; Paris Descartes University, USPC, Paris, France.
  • Léna H; Department of Respiratory Medicine, Pontchaillou Hospital, Rennes, France; University of Rennes, Rennes, France; Chemistry, Oncogenesis, and Stress Signaling, INSERM, Centre Eugène Marquis, Rennes, France.
  • Teulé A; Medical Oncology Department, Catalan Institute of Oncology (ICO-IDIBELL-ONCOBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Álvarez JV; Medical Oncology Department, Complejo Hospitalario de Zamora, Hospital Provincial, Zamora, Spain.
  • Raimbourg J; Medical Oncology Department, Institute de Cancerologie de l'Ouest, Nantes, France.
  • Hiret S; Medical Oncology Department, Institute de Cancerologie de l'Ouest, Nantes, France.
  • Lacroix L; Medical Biology and Pathology Department, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France.
  • Menéndez M; Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL-ONCOBELL-CIBERONC), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Saldaña J; Medical Oncology Department, Catalan Institute of Oncology (ICO-IDIBELL-ONCOBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Brunet J; Medical Oncology Department, Catalan Institute of Oncology-Badalona (ICO-Badalona), Institut Germans Trias i Pujol (IGTP), Badalona Applied Research Group in Oncology (B-ARGO), Universitat Autònoma de Barcelona (UAB), Medicine Department, Badalona, Spain.
  • Lianes P; Medical Oncology Department, Hospital de Mataró, Mataró, Spain.
  • Coupier I; Clinical Genetic Unit, Montpeiller Cancer Institut, CHU Montpellier, Montpeiller, France.
  • Auclin E; Gastrointestinal and Medical Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
  • Recondo G; INSERM, Gustave Roussy Cancer Campus, Université Paris Saclay, Saint-Aubin, France.
  • Friboulet L; INSERM, Gustave Roussy Cancer Campus, Université Paris Saclay, Saint-Aubin, France.
  • Adam J; Pathology Department, Gustave Roussy, Villejuif, France.
  • Green E; Inivata Ltd., Cambridge, United Kingdom.
  • Planchard D; Thoracic Oncology Group, Cancer Medicine Department, Gustave Roussy, Villejuif, France.
  • Frébourg T; Normandie Univ, UNIROUEN, INSERM, and Rouen University Hospital, Department of Genetics, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
  • Capellà G; Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL-ONCOBELL-CIBERONC), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Rouleau E; Medical Biology and Pathology Department, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France.
  • Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL-ONCOBELL-CIBERONC), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Caron O; Clinical Genetic Unit, Cancer Medicine Department, Gustave Roussy, Villejuif, France. Electronic address: olivier.caron@gustaveroussy.fr.
  • Besse B; Thoracic Oncology Group, Cancer Medicine Department, Gustave Roussy, Villejuif, France; INSERM, Gustave Roussy Cancer Campus, Université Paris Saclay, Saint-Aubin, France.
J Thorac Oncol ; 15(7): 1232-1239, 2020 07.
Article en En | MEDLINE | ID: mdl-32179180

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome de Li-Fraumeni / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Thorac Oncol Año: 2020 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome de Li-Fraumeni / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Thorac Oncol Año: 2020 Tipo del documento: Article País de afiliación: España